These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 23536196)

  • 21. Molecular mechanisms underlying the regulation and functional plasticity of FOXP3(+) regulatory T cells.
    Gao Y; Lin F; Su J; Gao Z; Li Y; Yang J; Deng Z; Liu B; Tsun A; Li B
    Genes Immun; 2012 Jan; 13(1):1-13. PubMed ID: 22048454
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Foxp3+ Helios+ regulatory T cells are expanded in active systemic lupus erythematosus.
    Alexander T; Sattler A; Templin L; Kohler S; Groß C; Meisel A; Sawitzki B; Burmester GR; Arnold R; Radbruch A; Thiel A; Hiepe F
    Ann Rheum Dis; 2013 Sep; 72(9):1549-58. PubMed ID: 23264341
    [TBL] [Abstract][Full Text] [Related]  

  • 23. From stability to dynamics: understanding molecular mechanisms of regulatory T cells through Foxp3 transcriptional dynamics.
    Bending D; Ono M
    Clin Exp Immunol; 2019 Jul; 197(1):14-23. PubMed ID: 30076771
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD26: a negative selection marker for human Treg cells.
    Salgado FJ; Pérez-Díaz A; Villanueva NM; Lamas O; Arias P; Nogueira M
    Cytometry A; 2012 Oct; 81(10):843-55. PubMed ID: 22949266
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Forced overexpression of either of the two common human Foxp3 isoforms can induce regulatory T cells from CD4(+)CD25(-) cells.
    Aarts-Riemens T; Emmelot ME; Verdonck LF; Mutis T
    Eur J Immunol; 2008 May; 38(5):1381-90. PubMed ID: 18412171
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distinct regulatory CD4+T cell subsets; differences between naïve and antigen specific T regulatory cells.
    Hall BM; Verma ND; Tran GT; Hodgkinson SJ
    Curr Opin Immunol; 2011 Oct; 23(5):641-7. PubMed ID: 21840184
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stability of regulatory T-cell lineage.
    Hori S
    Adv Immunol; 2011; 112():1-24. PubMed ID: 22118405
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Natural Treg cells spontaneously differentiate into pathogenic helper cells in lymphopenic conditions.
    Duarte JH; Zelenay S; Bergman ML; Martins AC; Demengeot J
    Eur J Immunol; 2009 Apr; 39(4):948-55. PubMed ID: 19291701
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FoxP3, Helios, and SATB1: roles and relationships in regulatory T cells.
    Grzanka J; Leveson-Gower D; Golab K; Wang XJ; Marek-Trzonkowska N; Krzystyniak A; Wardowska A; Mills JM; Trzonkowski P; Witkowski P
    Int Immunopharmacol; 2013 Jul; 16(3):343-7. PubMed ID: 23428911
    [TBL] [Abstract][Full Text] [Related]  

  • 30. T-cell proliferation and forkhead box P3 expression in human T cells are dependent on T-cell density: physics of a confined space?
    Bernardo D; Al-Hassi HO; Mann ER; Tee CT; Murugananthan AU; Peake ST; Hart AL; Knight SC
    Hum Immunol; 2012 Mar; 73(3):223-31. PubMed ID: 22248741
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human CD19(+)CD25(high) B regulatory cells suppress proliferation of CD4(+) T cells and enhance Foxp3 and CTLA-4 expression in T-regulatory cells.
    Kessel A; Haj T; Peri R; Snir A; Melamed D; Sabo E; Toubi E
    Autoimmun Rev; 2012 Jul; 11(9):670-7. PubMed ID: 22155204
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Foxp3 in control of the regulatory T cell lineage.
    Zheng Y; Rudensky AY
    Nat Immunol; 2007 May; 8(5):457-62. PubMed ID: 17440451
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterisation of Foxp3 splice variants in human CD4+ and CD8+ T cells--identification of Foxp3Δ7 in human regulatory T cells.
    Kaur G; Goodall JC; Jarvis LB; Hill Gaston JS
    Mol Immunol; 2010; 48(1-3):321-32. PubMed ID: 20688398
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1.
    Ono M; Yaguchi H; Ohkura N; Kitabayashi I; Nagamura Y; Nomura T; Miyachi Y; Tsukada T; Sakaguchi S
    Nature; 2007 Apr; 446(7136):685-9. PubMed ID: 17377532
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduction of Foxp3-expressing regulatory T cell infiltrates during the progression of renal allograft rejection in a mouse model.
    Wang S; Jiang J; Guan Q; Lan Z; Wang H; Nguan CY; Jevnikar AM; Du C
    Transpl Immunol; 2008 May; 19(2):93-102. PubMed ID: 18503884
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dynamics of peripheral tolerance and immune regulation mediated by Treg.
    Sakaguchi S; Wing K; Yamaguchi T
    Eur J Immunol; 2009 Sep; 39(9):2331-6. PubMed ID: 19662638
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activated and resting regulatory T cell exhaustion concurs with high levels of interleukin-22 expression in systemic sclerosis lesions.
    Mathian A; Parizot C; Dorgham K; Trad S; Arnaud L; Larsen M; Miyara M; Hié M; Piette JC; Frances C; Yssel H; Amoura Z; Gorochov G
    Ann Rheum Dis; 2012 Jul; 71(7):1227-34. PubMed ID: 22696687
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Flt3 ligand expands CD4+ FoxP3+ regulatory T cells in human subjects.
    Klein O; Ebert LM; Zanker D; Woods K; Tan BS; Fucikova J; Behren A; Davis ID; Maraskovsky E; Chen W; Cebon J
    Eur J Immunol; 2013 Feb; 43(2):533-9. PubMed ID: 23124877
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IL-2 contributes to maintaining a balance between CD4+Foxp3+ regulatory T cells and effector CD4+ T cells required for immune control of blood-stage malaria infection.
    Berretta F; St-Pierre J; Piccirillo CA; Stevenson MM
    J Immunol; 2011 Apr; 186(8):4862-71. PubMed ID: 21389253
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vivo expansion of CD4+Foxp3+ regulatory T cells mediated by GITR molecules.
    Nishioka T; Nishida E; Iida R; Morita A; Shimizu J
    Immunol Lett; 2008 Dec; 121(2):97-104. PubMed ID: 18930767
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.